Zhe-li Liu

Shenyang, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

AQUEOUS HUMOR CYTOKINE LEVELS AND REBOUND MACULAR EDEMA AFTER CONBERCEPT TREATMENT IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION.

AQUEOUS HUMOR CYTOKINE LEVELS AND REBOUND MACULAR EDEMA AFTER CONBERCEPT TREATMENT IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION.

Journal: Retina (Philadelphia, Pa.)
Published: March 23, 2021

Outcomes of Eyes Lost to Follow-Up in Patients with Central Retinal Vein Occlusion Who are Receiving Anti-Vascular Endothelial Growth Factor Treatment.

Outcomes of Eyes Lost to Follow-Up in Patients with Central Retinal Vein Occlusion Who are Receiving Anti-Vascular Endothelial Growth Factor Treatment.

Journal: Therapeutics and clinical risk management
Published: January 22, 2021

Comparison of the Effect of Intravitreal Conbercept and Ranibizumab on Aqueous Humor Cytokines in Central Retinal Vein Occlusion-Related Macular Edema.

Comparison of the Effect of Intravitreal Conbercept and Ranibizumab on Aqueous Humor Cytokines in Central Retinal Vein Occlusion-Related Macular Edema.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: November 20, 2020

Optical coherence tomography angiography characteristics in Waldenström macroglobulinemia retinopathy: A case report.

Optical coherence tomography angiography characteristics in Waldenström macroglobulinemia retinopathy: A case report.

Journal: World journal of clinical cases
Published: May 28, 2020

Assessment of conbercept therapy for high myopia macular neovascularization by optical coherence tomography angiography.

Assessment of conbercept therapy for high myopia macular neovascularization by optical coherence tomography angiography.

Journal: Scientific reports
Published: May 05, 2020

Effect of Platelet-Activating Factor on Barrier Function of ARPE-19 Cells.

Effect of Platelet-Activating Factor on Barrier Function of ARPE-19 Cells.

Journal: Drug design, development and therapy
Published: February 29, 2020

Conbercept and Ranibizumab Pretreatments in Vitrectomy with Silicone Oil Infusion for Severe Diabetic Retinopathy.

Conbercept and Ranibizumab Pretreatments in Vitrectomy with Silicone Oil Infusion for Severe Diabetic Retinopathy.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
Published: January 23, 2019

Interleukin-13 and age-related macular degeneration.

Interleukin-13 and age-related macular degeneration.

Journal: International journal of ophthalmology
Published: November 22, 2015

Interleukin-6 receptor blockade suppresses subretinal fibrosis in a mouse model.

Interleukin-6 receptor blockade suppresses subretinal fibrosis in a mouse model.

Journal: International journal of ophthalmology
Published: December 20, 2013

Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients.

Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients.

Journal: International journal of ophthalmology
Published: January 10, 2013

Incidence of Charles Bonnet syndrome after intravitreal bevacizumab injection in neovascular age-related macular degeneration.

Incidence of Charles Bonnet syndrome after intravitreal bevacizumab injection in neovascular age-related macular degeneration.

Journal: Acta ophthalmologica
Published: April 12, 2012

Transforming growth factor-β neutralizing antibodies inhibit subretinal fibrosis in a mouse model.

Transforming growth factor-β neutralizing antibodies inhibit subretinal fibrosis in a mouse model.

Journal: International journal of ophthalmology
Published: April 09, 2012
Showing 1-12 of 16

Last Updated: 09/26/2026